Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Plasma Cell × Cytarabine × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 115 Precursor Cell Lymphoblastic Leukemia-Lymphoma 47 Myelodysplastic Syndromes 25 Leukemia 25 Burkitt Lymphoma 23 Leukemia, Biphenotypic, Acute 17 Recurrence 14 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13 Lymphoma, Mantle-Cell 12 Leukemia, Myelomonocytic, Chronic 10 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 8 Myeloproliferative Disorders 8 Lymphoma, Non-Hodgkin 8 Lymphoma 8 Sarcoma, Myeloid 5 Neoplasm, Residual 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia, Monocytic, Acute 5 Hodgkin Disease 5 Leukemia, Myelomonocytic, Acute 4 Hematologic Neoplasms 4 Lymphoma, Follicular 3 Down Syndrome 3 Blast Crisis 3 Multiple Myeloma 2 Lymphoma, T-Cell 2 Lymphoma, B-Cell 2 Leukemia, Myelomonocytic, Juvenile 2 Leukemia, Myeloid, Accelerated Phase 2 Leukemia, Myeloid 2

Interventions

Dexamethasone 16 Lenalidomide 12 Bortezomib 9 Cyclophosphamide 7 carfilzomib 6 Whole-Body Irradiation 6 Melphalan 6 fludarabine 5 daratumumab 5 Tacrolimus 5 Mycophenolic Acid 5 Calcium Dobesilate 5 pomalidomide 3 fludarabine phosphate 3 belantamab mafodotin 3 Radiotherapy 3 gamma-Globulins 2 elotuzumab 2 Trimethoprim, Sulfamethoxazole Drug Combination 2 Sirolimus 2 Prednisone 2 Immunoglobulins, Intravenous 2 Hematopoietic Stem Cell Transplantation 2 Etoposide 2 venetoclax 1 thymoglobulin 1 siltuximab 1 poly ICLC 1 pembrolizumab 1 ixazomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡